TLDR 58% of men aged 30-50 have hair loss, with severity increasing with age.
This study examined the prevalence and pattern of male androgenetic alopecia in a population-based sample of 1,005 men aged 30-50 years. 58% of the participants were found to have AGA, with Grade II being the most common type (27.27%), followed by Grade I (22.12%) and Grade III (21.78%). The prevalence increased with age, while the grade also increased as age went up. 12.9% had grades IV to VI which would benefit from hair transplantation, while 44.1% had grades I to III and are potential candidates for medical treatment.
82 citations,
September 2008 in “Journal of Investigative Dermatology” EDA2R gene linked to hair loss.
29 citations,
July 2003 in “PubMed” Hair loss affects both genders and can impact well-being, with treatments available for various types.
174 citations,
November 2002 in “Expert Reviews in Molecular Medicine” Hair loss needs more research for better treatments.
4 citations,
May 2002 in “Therapeutische Umschau” AGA treated with finasteride, minoxidil, and hair transplantation.
17 citations,
November 2021 in “Journal of Cosmetic Dermatology” Combination therapies for androgenetic alopecia work best but can have significant side effects and costs.
1 citations,
March 2021 in “Dermatological reviews” AGA, a common hair loss, is caused by genetics, hormones, age, and environmental factors.
46 citations,
May 2018 in “Dermatologic Surgery” PRP injections effectively treat hair loss, with positive results in both monthly and every three months treatments.
1 citations,
January 2009 in “CRC Press eBooks” Finasteride increases hair count and improves hair growth with low risk of side effects.
Curcuma aeruginosa Roxb. may help treat hair loss by affecting specific biological pathways.
18 citations,
May 2015 in “Australasian Journal of Dermatology” Serenoa repens extract in topical products improves hair growth and appearance in male pattern baldness with mild side-effects.
